Risk-stratified changes in left atrial strain during chemotherapy: preliminary data

Clicks: 1
ID: 323273
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #190 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Alterations in left atrial strain (LAS) may reflect early functional changes not captured by conventional cancer-therapy-related cardiac dysfunction indices. However, how LAS evolves during chemotherapy and whether its trajectory differs according to baseline cardiovascular risk remain unclear. Purpose To evaluate longitudinal changes in LAS during chemotherapy and to determine whether these changes differ according to baseline cardiovascular risk. Methods In a prospective cohort study, 71 women with breast cancer undergoing anthracycline based potentially cardiotoxic chemotherapy were stratified into low-risk (n=40) and moderate/high-risk (n=31) groups according to the HFA-ICOS risk assessment. LAS components corresponding to reservoir, conduit, and contractile function—expressed as peak atrial longitudinal strain (PALS), peak atrial conduit strain, and peak atrial contraction strain (PACS)—were assessed using speckle-tracking echocardiography at baseline, after 4 cycles, and after 8 cycles of chemotherapy following a standardized acquisition protocol. Longitudinal changes were analysed using linear mixed-effects models with random intercepts, including time, risk group, and time×group interaction as fixed effects. Where appropriate, within-group temporal changes were explored using Friedman tests with Bonferroni-adjusted post hoc comparisons. Results Across the entire cohort, significant time effects were observed for all LAS components (all p<0.001). PALS demonstrated similar trajectories in both risk groups, characterised by an early decline after 4 cycles with partial recovery by 8 cycles, with no evidence of a differential trajectory according to baseline risk (time×group p=0.927). In contrast, peak atrial conduit strain showed a significant time×group interaction (p=0.012), with greater impairment by the end of chemotherapy in the moderate/high-risk group compared with the low-risk group (Figure 1). Similarly, PACS demonstrated a significant time×group interaction (p=0.008), indicating more pronounced deterioration in atrial contractile function among patients with higher baseline cardiovascular risk (Figure 2). Conclusions LAS components exhibit dynamic changes during chemotherapy with distinct risk-dependent patterns. While LA reservoir function follows comparable trajectories regardless of baseline cardiovascular risk, conduit and contractile strain components demonstrate greater impairment in patients at moderate to high risk. These findings suggest that LAS analysis provides complementary information for early cardiac functional assessment in cardio-oncology beyond conventional ventricular indices.Figure 1 Figure 2
Reference Key
openalex_W7172268424 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors B Zholdin, A Amanova, S Balmagambetova, G Kurmanalina, I Talipova, G Sultanbekova, K Kubenova, S Madinova, M Baspayeva, Z Bulekova, Z H Tlegenova
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2026
DOI
10.1093/eurheartjsupp/suag097.110
URL
https://doi.org/10.1093/eurheartjsupp/suag097.110
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.